The recurrent architecture of tumour initiation, progression and drug sensitivity

Area of Science:

• Oncology
• Systems Biology
• Genomics

Background:

• Genomic alterations in tumors often converge on functional master regulator (MR) proteins.
• These MR proteins form autoregulated modules, termed tumor checkpoints, essential for maintaining cancer cell states.
• Aberrant MR protein activity is frequently due to post-translational modifications rather than genetic mutations or expression changes, complicating conventional identification.

Purpose of the Study:

• To discuss novel methods for systematic analysis of MR proteins.
• To explore the modular regulatory architecture implemented by MR proteins.
• To highlight the potential of MR proteins as biomarkers and therapeutic targets in cancer.

Main Methods:

• Review of recent studies identifying recurrent regulatory architectures in various tumor types.
• Discussion of novel analytical methods for MR protein identification.
• Framework for studying genetic heterogeneity and translational applications.

Main Results:

• Identification of a conserved regulatory architecture involving MR proteins and tumor checkpoints across multiple cancer types.
• Recognition of MR proteins as key drivers of tumor cell state maintenance.
• Highlighting the challenge in identifying MR proteins due to post-translational dysregulation.

Conclusions:

• MR proteins and their associated tumor checkpoints represent promising biomarkers and therapeutic targets.
• Novel methods are crucial for the systematic analysis of MR proteins and their regulatory networks.
• Understanding this modular architecture offers a reductionist framework for studying cancer heterogeneity and driving translational research.